TY  - JOUR

T1  - DHA-paclitaxel (Taxoprexin) as first-line treatment in patients with stage IIIB or IV non-small cell lung cancer: report of a phase II open-label multicenter trial.

JO  - J Thorac Oncol

PY  - 2006/11/01

AU  - Payne M

AU  - Ellis P

AU  - Dunlop D

AU  - Ranson M

AU  - Danson S

AU  - Schacter L

AU  - Talbot D

ED  - 

VL  - 1

IS  - 9

SP  - 984

EP  - 990

Y2  - 2024/12/26

ER  -